by Collectif | 1 Dec, 2015 | Bioethics press synthesis | Embryo research and alternatives
On Tuesday, CellProthera[1]start-up organisation announced the launch of a clinical trial in 2016 to test “innovative experimental treatment” on “fifty or so” cardiac patients. The trial, which will be carried out in France, the United Kingdom and Singapore, has...
by Collectif | 29 Nov, 2015 | Bioethics press synthesis | MAP – Surrogacy
Men bring children into the world? This may be feasible. According to Dr. Karine Chung, Director of the Fertility Preservation Programme at the Keck School of Medicine, University of Southern California, it will be possible “to transplant uteruses in men to allow them...
by Collectif | 25 Nov, 2015 | Bioethics press synthesis | MAP – Surrogacy
When New York Governor, Andrew Cuomo, recently considered lifting the surrogacy ban in place in his State since 1993, a new surrogacy case came to light. It focused on the conflict between a man and the Californian surrogate mother with whom he signed an...
by Collectif | 25 Nov, 2015 | Bioethics press synthesis | Abortion - Medical termination of Pregnancy(MTP)
In Peru, the Parliamentary Laws’ Commission has rejected the draft law “to decriminalise abortion in the case of rape, thus ruling out the opportunity for a Parliamentary debate prior to closure of the Parliamentary session in July 2016”. The debate was held in...
by Collectif | 24 Nov, 2015 | Bioethics press synthesis | Organ donation
From 1 December, Wales will be the first country in the United Kingdom to introduce a major change in the conditions governing organ donation. Any person aged 18 or over, who has lived in Wales for more than one year and who dies there will be considered a potential...
by Collectif | 24 Nov, 2015 | Bioethics press synthesis | Organ donation
Further to last June’s announcement, the Carmat Biotechnology Company was granted authorisation on Tuesday, 24 November 2015 by the French medical authorities [1]to perform a fourth artificial heart implant. The aim is to complete the initial trial phase [2]: “By...